Edition:
India

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

155.74USD
22 Jan 2020
Change (% chg)

$0.47 (+0.30%)
Prev Close
$155.27
Open
$155.69
Day's High
$156.45
Day's Low
$154.54
Volume
645,340
Avg. Vol
428,368
52-wk High
$156.97
52-wk Low
$110.63

Latest Key Developments (Source: Significant Developments)

Mckesson Sees Adj Earnings Per Diluted Share Of $14.60 To $14.80 For FY 2020
Tuesday, 14 Jan 2020 

Jan 13 (Reuters) - McKesson Corp ::SEES FY 2020 ADJUSTED EARNINGS PER SHARE $14.60 TO $14.80.NOW ANTICIPATES ADJUSTED EARNINGS PER DILUTED SHARE OF $14.60 TO $14.80 FOR FULL-YEAR FISCAL 2020.FY2020 EARNINGS PER SHARE VIEW $14.37 -- REFINITIV IBES DATA.  Full Article

Mckesson Corp Enters Into Credit Agreement - SEC Filing
Saturday, 28 Sep 2019 

Sept 27 (Reuters) - McKesson Corp ::MCKESSON CORP SAYS ON SEPTEMBER 25, CO ENTERED INTO A CREDIT AGREEMENT - SEC FILING.MCKESSON CORP - UNDER NEW CREDIT FACILITY CO HAS REVOLVING LINE OF CREDIT AVAILABLE OF UP TO $4.0 BILLION.MCKESSON CORP - NEW CREDIT FACILITY IS SCHEDULED TO MATURE IN SEPTEMBER 2024.MCKESSON CORP - UNDER NEW CREDIT FACILITY CO HAS A $3.6 BILLION AGGREGATE SUBLIMIT OF AVAILABILITY IN CANADIAN DOLLARS, BRITISH POUNDS STERLING AND EUROS.  Full Article

Mckesson Corp Exec Says Expects Modest Impact From New Generic Launches In FY2020
Wednesday, 8 May 2019 

May 8 (Reuters) - McKesson Corp ::EXEC SAYS REGULATORY IMPACTS, PARTICULARLY IN INTERNATIONAL RETAIL MARKETS AMONG OTHER THINGS WILL CONTINUE TO CONFRONT US IN FISCAL 2020 - CONF CALL.EXEC SAYS EXPECTS BRANDED DRUG PRICES TO RISE IN MID-SINGLE DIGIT PERCENTAGES IN FISCAL 2020 - CONF CALL.EXEC SAYS EXPECTS OPIOID-RELATED LITIGATION COSTS OF ABOUT $150 MILLION IN FISCAL 2020 - CONF CALL.EXEC SAYS EXPECTS MODEST IMPACT FROM NEW GENERIC LAUNCHES IN FY2020 - CONF CALL.  Full Article

Brian Tyler Becomes Mckesson’S New CEO
Monday, 1 Apr 2019 

April 1 (Reuters) - McKesson Corp ::BRIAN TYLER BECOMES MCKESSON’S NEW CEO.MCKESSON CORP - IRVING, TEXAS OFFICIALLY MCKESSON'S NEW GLOBAL HEADQUARTERS.MCKESSON CORP - TYLER BECOMES COMPANY'S NEW CHIEF EXECUTIVE OFFICER TODAY, SUCCEEDING JOHN HAMMERGREN.  Full Article

McKesson Announces New Global Headquarters In Las Colinas, Texas
Saturday, 1 Dec 2018 

Nov 30 (Reuters) - McKesson Corp ::MCKESSON ANNOUNCES NEW GLOBAL HEADQUARTERS IN LAS COLINAS, TEXAS.MCKESSON CORP - COMPANY TO MOVE MOST SAN FRANCISCO BAY AREA JOBS TO LAS COLINAS AND OTHER MCKESSON HUB LOCATIONS BY JAN 1, 2021.MCKESSON CORP - PLANS TO OPTIMIZE COST STRUCTURES WILL GENERATE APPROXIMATELY $300 MILLION TO $400 MILLION BY END OF FISCAL 2021.  Full Article

McKesson CEO John Hammergren Announces Retirement
Friday, 2 Nov 2018 

Nov 1 (Reuters) - McKesson Corp ::JOHN HAMMERGREN ANNOUNCES RETIREMENT; BRIAN TYLER TO BECOME MCKESSON’S CEO AND EDWARD MUELLER TO CHAIR BOARD.MCKESSON CORP - JOHN H. HAMMERGREN, CHAIRMAN AND CHIEF EXECUTIVE OFFICER, HAS DECIDED TO RETIRE, EFFECTIVE MARCH 31, 2019.  Full Article

McKesson Lowers Assumption For Branded Pharmaceutical Price Increases In U.S. To Mid-Single Digit Pct
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - McKesson Corp ::MCKESSON SAYS LOWERED ASSUMPTION FOR BRANDED PHARMACEUTICAL PRICE INCREASES IN U.S. TO MID-SINGLE DIGIT PERCENT FROM MID-TO-HIGH-SINGLE DIGIT PERCENT - CONF CALL.MCKESSON, ON GENERICS PRICING, SAYS ON THE SELL SIDE, CONTINUE TO SEE A "VERY COMPETITIVE YET STABLE ENVIRONMENT" - CONF CALL.  Full Article

McKesson Q2 Adjusted Earnings Per Share $3.60
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - McKesson Corp ::MCKESSON REPORTS FISCAL 2019 SECOND-QUARTER RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $3.60.Q2 GAAP EARNINGS PER SHARE $2.51 FROM CONTINUING OPERATIONS.Q2 REVENUE $53.1 BILLION VERSUS I/B/E/S VIEW $53.64 BILLION.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $13.20 TO $13.80.Q2 EARNINGS PER SHARE VIEW $3.28 -- THOMSON REUTERS I/B/E/S.BOARD OF DIRECTORS YESTERDAY DECLARED A REGULAR DIVIDEND OF THIRTY-NINE CENTS PER SHARE OF COMMON STOCK.  Full Article

Mckesson Relaunched Biopharmaceutical Services Business As Mckesson Life Sciences
Monday, 22 Oct 2018 

Oct 22 (Reuters) - McKesson Corp ::MCKESSON - RELAUNCHED BIOPHARMACEUTICAL SERVICES BUSINESS UNDER ITS U.S. PHARMACEUTICAL AND SPECIALTY HEALTH BUSINESS UNIT AS MCKESSON LIFE SCIENCES.  Full Article

EKF Diagnostics Signs Private Label Distribution Agreement
Thursday, 9 Aug 2018 

Aug 9 (Reuters) - EKF Diagnostics Holdings PLC ::ANNOUNCES THAT IT HAS SIGNED A PRIVATE LABEL DISTRIBUTION AGREEMENT WITH MCKESSON MEDICAL-SURGICAL.PRIVATE LABEL DISTRIBUTION AGREEMENT FOR DIASPECT TM.  Full Article

Photo

U.S. prosecutors open criminal probe of opioid makers, distributors

Federal prosecutors are investigating six pharmaceutical companies for potential criminal charges in connection with shipping big quantities of opioid painkillers that contributed to a healthcare crisis, according to regulatory filings.